Mobile Menu

  • AboutUs_Normal-24 The EyeCRO Approach
    • About Us
    • Careers
    • Location
    • Partners
  • MiDrops MiDROPS™
  • InVivo Models
    • Allergic Conjunctivitis
    • Corneal Sensitivity
    • Corneal Wound Healing
    • Diabetic Keratopathy
    • Dry Eye Disease
    • Endotoxin induced Uveitis
    • Experimental Autoimmune Uveitis
    • Geographic Atrophy
    • Inherited Retinal Degenerations
    • Ischemia Reperfusion Injury
    • Laser-induced Choroidal Neovascularization
    • Light Damaged
    • Optic Nerve Crush
    • Oxygen Induced Retinopathy
    • Retinal Detachment
    • Retinal Vein Occlusion
    • Rotenone-induced Optic Neuropathy
    • STZ-induced Diabetic Retinopathy
    • VEGF-induced permeability
  • InVitro Capabilities
    • Biochemistry
    • Bioanalytical Detection
    • GLP Toxicology and PK Studies
    • Histology
    • Ophthalmic Imaging and Physiology
  • News News
  • ContactUs Contact Us
  • Menu
  • Skip to primary navigation
  • Skip to main content

EyeCRO Logo

  • AboutUs_Normal-24 The EyeCRO Approach
    • About Us
    • Careers
    • Location
    • Partners
  • MiDrops MiDROPS™
  • InVivo Models
    • Allergic Conjunctivitis
    • Corneal Sensitivity
    • Corneal Wound Healing
    • Diabetic Keratopathy
    • Dry Eye Disease
    • Endotoxin induced Uveitis
    • Experimental Autoimmune Uveitis
    • Geographic Atrophy
    • Inherited Retinal Degenerations
    • Ischemia Reperfusion Injury
    • Laser-induced Choroidal Neovascularization
    • Light Damaged
    • Optic Nerve Crush
    • Oxygen Induced Retinopathy
    • Retinal Detachment
    • Retinal Vein Occlusion
    • Rotenone-induced Optic Neuropathy
    • STZ-induced Diabetic Retinopathy
    • VEGF-induced permeability
  • InVitro Capabilities
    • Biochemistry
    • Bioanalytical Detection
    • GLP Toxicology and PK Studies
    • Histology
    • Ophthalmic Imaging and Physiology
  • News News
  • ContactUs Contact Us

Preclinical Ophthalmic Contract Research

News

How-to Improve Your Work Related Publishing

November 14, 2016 //  by Danny Smith

How to Start Off Coaching Spanish - Morning of School Actions Why Do I Need grammarservices.com? English is the language of international intercommunication, and billions of people use it permanently for many reasons . One of the impressing obstacles which plenty of learners, educators , authors, employed professionals and dealers have is the necessity to demonstrate a good level of written …

Category: uncategorized

Items to Make With Document

November 11, 2016 //  by Danny Smith

There is a study executed to investigate an existing or a matter that was emerging in confirmed discipline and at a time that was chosen. Two techniques have already been widely-used in performing doctoral and education studies. …

Category: Top News

Cause of inflammation in diabetes identified

November 9, 2016 //  by stanselb

Inflammation is one of the main reasons why people with diabetes experience heart attacks, strokes, kidney problems and other, related complications. Now, in a surprise finding, researchers at Washington University School of Medicine in St. Louis have identified a possible trigger of chronic inflammation.  Through a series of experiments in the animals and in cell cultures, the researchers, …

Category: NewsTag: biochemisty, biology, chronic inflammation, diabetes, drug development, medical research

Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models

October 20, 2016 //  by stanselb

Experimental and clinical data suggest that pro-angiogenic, pro-inflammatory and mitogenic cytokine leptin can be implicated in ocular neovascularization and the other eye pathologies.  At least in part, leptin action appears to be mediated through functional interplay with vascular endothelial growth factor (VEGF).  The effects of VEGF on leptin expression were assessed in ocular endothelial cell …

Category: NewsTag: eye pathology, ocular neovascularization, ophthalmic development, Ophthalmology, Rafal Farjo Ph.D, vascular endothelial growth factor

Data Monitoring Committee Recommends Continuation of APOLLO Phase 3 Clinical Trial of Patisiran for Hereditary ATTR Amyloidosis with Polyneuropathy (hATTR-PN)

October 11, 2016 //  by stanselb

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, announced today that the Data Monitoring Committee (DMC) for the Phase 3 APOLLO study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy (hATTR-PN) met on October 7, 2016 and recommended continuation of the trial without modification. Read the entire …

Category: News

Patient-reported outcomes and visual acuity after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting

October 4, 2016 //  by stanselb

This study was an evaluation, at 12 months follow-up, of anti VEGF treatment for diabetic macular edema conducted in a real world setting.  To examine objective visual acuity measured with ETDRS, retinal thickness (OCT), patient reported outcome and describe levels of glycated hemoglobin and its association with the effects on visual acuity in patients treated with anti-VEGF for visual impairment …

Category: NewsTag: anti-VEGF, Diabetic Macular Edema, DME, OCT, ophthalmic research, optical coherence tomography, retinal thickness, visual acuity, visual impairment

Surgeons perform world’s first operation inside the eye using a robot

September 20, 2016 //  by stanselb

Robert MacLaren, Professor of Ophthalmology. assisted by Dr Thomas Edwards, Nuffield Medical Fellow, used the remotely controlled robot to lift a membrane 100th of a millimetre thick from the retina at the back of the right eye of the Revd Dr William Beaver, 70, an Associate Priest at St Mary the Virgin, Iffley, Oxford. He is the first patient ever to undergo this experimental procedure. Read the …

Category: NewsTag: ophthalmic developement, Ophthalmology, retina

Allergan Makes an Eye-Opening Acquisition

August 24, 2016 //  by stanselb

Global pharmaceutical company Allergan (NYSE:AGN) may have just revealed its plans for the future.  On Aug. 11, the company announced its plan to acquire ForSight Vision5, a privately held biotech.  Allergan will pay $95 million up front and will also pay a milestone payment next year if ForSight's innovative glaucoma treatment device makes it through the FDA gauntlet and is successfully launched. …

Category: NewsTag: contract research organizations, eye drops, glaucoma, ophthalmic research, Ophthalmology

Curing blindness by repairing corneas with invisible films

August 16, 2016 //  by stanselb

The University of Melbourne–lead team of researchers have grown corneal cells on a layer of film that can be implanted in the eye to help the cornea heal itself. They have successfully restored vision in animal trials and are aiming to move to human trials next year.  "The hydrogel film we have developed allows us to grow a layer of corneal cells in the laboratory," says Berkay. "Then, we can …

Category: NewsTag: blindness, corneal cells, corneal implant, front of the eye research

Interim results from clinical trial demonstrate safety of cell-based therapy for retinitis pigmentosa

August 4, 2016 //  by stanselb

Regenerative medicine company jCyte and the Sue & Bill Gross Stem Cell Research Center at the University of California, Irvine report that their investigational therapy for retinitis pigmentosa (RP) has demonstrated a favorable safety and tolerability profile in an ongoing Phase I/II clinical trial.  The cell-based approach taken is intended to rescue sick and dying retinal photoreceptor cells …

Category: NewsTag: ophthalmic disease, rescue retinal photoreceptors, retina, retinitis pigmentosa, RP

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 13
  • Go to Next Page »

© 2021 · EyeCRO · All Rights Reserved.